CreatiVasc also utilizes the expertise and guidance of a seasoned group of medical and clinical leaders who comprise the company’s Technical Advisory Committee. This group is tapped to assess technical, clinical and FDA regulatory issues associated with the company’s focus on the vascular technology field.

The CreatiVasc Technical Advisory Committee provides a real-world perspective on the medical needs, device engineering and FDA regulatory approval issues that surround the successful development and launch of medical devices. This group provides a “reach-back” capability to valued clinical expertise within the vascular surgery and dialysis communities.

Learn more about the CreatiVasc Technical Advisory Committee:

• Spence M. Taylor, MD FACS
• Eugene M. Langan, III MD FACS
  
• Hugh H. Trout III MD FACS